New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies

Por Marc-Oliver Grimm, Katharina Leucht, Viktor Grünwald, Susan Foller
Publicado em 2020-02-01

Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies

Por Christoph Werner, Olaf Dirsch, Uta Dahmen, Marc-Oliver Grimm, Stefan Schulz, Amelie Lupp
Publicado em 2020-09-01